HBV resistance/subtype
| Material: | 2 ml EDTA-blood (Sending of new material is not required if a PCR was carried out within the past 3 months) |
| Methods: | Amplifikationsverfahren → PCR und Sequenzierung |
| Indication | Suspicion of antiviral therapy failure. Suspicion of resistant HBV transmission. Support in the decision making process of what the therapy of choice is, especially whether interferon therapy is indicated. |
| Accredited | ja |
More Results for the letter H
- HIV (Human immune deficiency virus) (HIV, HIVBL)
- HIV-antibodies, HIV-1-/HIV-2 screening test, HIV-1-/HIV-2 immunoblot
- HIV resistance assessment (HIVRES)
- HLA B27 (HLAB)
- PCR
- HLA DR, DQ (HLAD)
- HLA typing (HLA)
- Human leucocyte antigen, HLA-A, -B, -C, -DR, full typing
- HLA-B-27 (HLA27P)
- HLA-B-5701 (HLAB57)
- Holotranscobalamin (HOLO)
- HOMA-IR (evaluation of insulin resistance) (HOMA)
- Homocysteine, total (HOMOC)
- Homocystine (HOMOCU)
- Homogentisic acid (HOMOG)
- Homovanillic acid (HVS)
- Homovanillinic acid (HOMO04)
- HVA
- Hookworm (ANDUO, NECA)
- European hookworm, ancylostoma duodenale, necator americanus
- Howell-Jolly bodies (HOJO)
- HTLV-I/II (HTLV, HTLVQ)
- Human T-lymphotropic viruses, human T-cell leukemia viruses
- Human metapneumovirus (HMPV)
- Hydroxybutyrate (HYDR01)
- b-Hydroxybutyrate
- Hydroxycorticosteroids (-17) in urine (HYDRO17)
- Hydroxylase deficiency (CYP11B1), genetic analysis (11β-) (HYDR03(11b))
- Hydroxylase deficiency (CYP21), genetic analysis (21-) (HYDR02(21))
- Hydroxyprogesterone (17α-) (HYDR04(17α))
- Hydroxyproline, total in urine (HYPRU1)
- Hydroxypyren (1-) (HYDR06(1))
- metabolite of polycyclic aromatic hydrocarbons
- Hygiene examinations in hospital (HYG)
- Hymenolepis nana (HYMENO)
- Dwarf tapeworm